Royal Fund Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.04M | Buy |
22,196
+1,177
| +6% | +$403K | 0.67% | 42 |
|
|
2026
Q1 | $7.41M | Buy |
21,019
+342
| +2% | +$122K | 0.7% | 40 |
|
|
2025
Q4 | $6.78M | Buy |
20,677
+3,649
| +21% | +$1.16M | 0.62% | 55 |
|
|
2025
Q3 | $4.81M | Sell |
17,028
-5,156
| -23% | -$1.5M | 0.57% | 57 |
|
|
2025
Q2 | $6.2M | Buy |
22,184
+2,388
| +12% | +$677K | 0.62% | 47 |
|
|
2025
Q1 | $6.31M | Sell |
19,796
-281
| -1% | -$83K | 0.7% | 42 |
|
|
2024
Q4 | $5.35M | Buy |
20,077
+4,942
| +33% | +$1.47M | 0.5% | 61 |
|
|
2024
Q3 | $5.01M | Sell |
15,135
-939
| -6% | -$307K | 0.3% | 90 |
|
|
2024
Q2 | $5.15M | Sell |
16,074
-1,304
| -8% | -$383K | 0.42% | 47 |
|
|
2024
Q1 | $4.96M | Buy |
17,378
+2,914
| +20% | +$853K | 0.49% | 62 |
|
|
2023
Q4 | $4.18M | Sell |
14,464
-669
| -4% | -$182K | 0.46% | 60 |
|
|
2023
Q3 | $4.07M | Sell |
15,133
-212
| -1% | -$52.9K | 0.55% | 58 |
|
|
2023
Q2 | $3.41M | Sell |
15,345
-4,569
| -23% | -$1.06M | 0.42% | 76 |
|
|
2023
Q1 | $4.81M | Buy |
19,914
+37
| +0.2% | +$9.08K | 0.69% | 53 |
|
|
2022
Q4 | $5.22M | Buy |
19,877
+305
| +2% | +$81.8K | 0.83% | 38 |
|
|
2022
Q3 | $4.41M | Buy |
19,572
+117
| +0.6% | +$28.4K | 0.8% | 48 |
|
|
2022
Q2 | $4.73M | Buy |
19,455
+650
| +3% | +$159K | 0.79% | 48 |
|
|
2022
Q1 | $4.55M | Sell |
18,805
-463
| -2% | -$106K | 0.66% | 54 |
|
|
2021
Q4 | $4.33M | Buy |
19,268
+6,177
| +47% | +$1.3M | 0.62% | 60 |
|
|
2021
Q3 | $2.78M | Buy |
13,091
+1,154
| +10% | +$266K | 0.41% | 84 |
|
|
2021
Q2 | $2.91M | Sell |
11,937
-5,902
| -33% | -$1.45M | 0.48% | 77 |
|
|
2021
Q1 | $4.44M | Buy |
17,839
+2,907
| +19% | +$694K | 0.81% | 47 |
|
|
2020
Q4 | $3.43M | Sell |
14,932
-3,674
| -20% | -$847K | 0.73% | 59 |
|
|
2020
Q3 | $4.73M | Sell |
18,606
-21
| -0.1% | -$5.2K | 1.21% | 23 |
|
|
2020
Q2 | $4.39M | Buy |
18,627
+2,716
| +17% | +$620K | 1.55% | 13 |
|
|
2020
Q1 | $3.23M | Sell |
15,911
-10,058
| -39% | -$2.2M | 1.31% | 22 |
|
|
2019
Q4 | $6.26M | Buy |
25,969
+1,979
| +8% | +$436K | 1.59% | 20 |
|
|
2019
Q3 | $4.64M | Buy |
23,990
+1,318
| +6% | +$253K | 1.29% | 30 |
|
|
2019
Q2 | $4.18M | Sell |
22,672
-14,821
| -40% | -$2.65M | 1.24% | 30 |
|
|
2019
Q1 | $7.12M | Buy |
37,493
+606
| +2% | +$116K | 2.27% | 14 |
|
|
2018
Q4 | $7.18M | Sell |
36,887
-990
| -3% | -$193K | 2.91% | 4 |
|
|
2018
Q3 | $7.85M | Sell |
37,877
-318
| -0.8% | -$62.7K | 2.44% | 9 |
|
|
2018
Q2 | $7.05M | Sell |
38,195
-703
| -2% | -$124K | 2.33% | 12 |
|
|
2018
Q1 | $6.63M | Buy |
38,898
+38,880
| +216,000% | +$7.14M | 2.42% | 12 |
|
|
2017
Q4 | $3K | Buy |
+18
| New | +$3.19K | ﹤0.01% | 538 |
|
|
2017
Q3 | – | Sell |
-130
| Closed | -$22K | – | 454 |
|
|
2017
Q2 | $22K | Buy |
+130
| New | +$21.1K | 0.01% | 212 |
|
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
Royal Fund Management's AMGN Position: Q2 2026 in Review
Royal Fund Management increased its Amgen (AMGN) stake by 5.6% in Q2 2026, buying an estimated $403K and bringing the position to 22,196 shares worth $8.04M. The position accounts for 0.67% of the portfolio, ranked #42.
Royal Fund Management first reported a position in AMGN in Q2 2017 and has held it in 36 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Royal Fund Management held 22,196 shares of Amgen worth $8.04M as of Q2 2026.
- Royal Fund Management bought 1,177 Amgen shares in Q2 2026, an estimated $403K.
- Amgen made up 0.67% of Royal Fund Management's portfolio in Q2 2026, its #42 holding.
- Royal Fund Management first reported a position in Amgen in Q2 2017 and has held it in 36 quarters since.
- 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Royal Fund Management's 13F filing for Q2 2026, filed 20 Jul 2026.